SCHEMBL16787448

SCHEMBL16787448

Cc1cncc2[nH]c(=O)n(CC(F)(F)F)c12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
QPCT Q16769 1/20 0.33
DDR1 Q08345 3/20 0.32
AR P10275 1/20 0.32
METAP2 P50579 7/20 0.32
CDC7 O00311 1/20 0.32
GRIN1 Q05586 2/20 0.31
GRIN2B Q13224 2/20 0.31
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30
HSD17B10 Q99714 1/20 0.30
MEN1 O00255 1/20 0.30
CYP1A2 P05177 1/20 0.30
KMT2A Q03164 1/20 0.30
ADORA3 P0DMS8 1/20 0.30
ADORA2A P29274 1/20 0.30
ADORA1 P30542 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16787428 0.84 METAP2 (0.37) ALDH1A1LMNAHTTSMN1; SMN2DDR1
SCHEMBL16787441 0.82 METAP2 (0.36) DDR1METAP2CDC7
SCHEMBL18464810 0.75 DAO (0.43) DDR1METAP2CDC7MEN1CYP1A2
SCHEMBL23202176 0.72 LMNA (0.37) ALDH1A1LMNAMETAP2GRIN1GRIN2B
SCHEMBL16787432 0.67 LMNA (0.42) ALDH1A1LMNAHTTSMN1; SMN2AR
SCHEMBL15552906 0.67 JAK2 (0.48)
SCHEMBL10085013 0.64 DDR1 (0.52) ALDH1A1DDR1MEN1CYP1A2KMT2A
SCHEMBL4175626 0.64 MEN1 (0.62) ALDH1A1LMNAHTTSMN1; SMN2HPGD
SCHEMBL6242682 0.62 CYP1A2 (0.64) ALDH1A1SMN1; SMN2HPGDTSHRHSD17B10
SCHEMBL16322281 0.62 KMT2A (0.57) ALDH1A1LMNASMN1; SMN2ARMETAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175608-A1 NOVEL 4-SUBSTITUTED 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN INFECTIOUS DISEASES BVBA (BE) 2015-06-25 US disclosed
US-20150175608-A1 NOVEL 4-SUBSTITUTED 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN INFECTIOUS DISEASES BVBA (BE) 2015-06-25 US disclosed
US-20150158862-A1 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN R&D IRELAND (US) 2015-06-11 US disclosed
US-20150158862-A1 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN R&D IRELAND (US) 2015-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150158862-A1 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS ZC3HAV1, HELZ, SARS1 ALDH1A1 3047/4885LMNA 1821/4885HTT 1042/4885
US-20150175608-A1 NOVEL 4-SUBSTITUTED 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS SARS1, HRH4, H1-4 ALDH1A1 2742/4885LMNA 2061/4885HTT 1655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.